Business Context and Reporting Period
Company: BayFirst Financial Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: July 30, 2025
Reporting Period: Second Quarter ended June 30, 2025
Context: The filing serves as a Regulation FD disclosure announcing a conference call held to discuss financial results for the quarter ended June 30, 2025. The company is an emerging growth company listed on The Nasdaq Stock Market LLC under the symbol BAFN.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. This 8-K filing acts solely as a notification of the conference call and does not include the financial statements or results themselves.
Material Changes
No material changes to financial performance or operations are detailed in this document. The filing references a conference call transcript (Exhibit 99.1) where such details would be discussed, but the text of the 8-K itself does not report specific changes versus prior periods.
Guidance, Outlook, and Risks
Management Commentary: Management hosted a conference call on July 30, 2025, to discuss the Q2 2025 results. The transcript is available as Exhibit 99.1 and on the company's Investor Relations website.
Risks and Contingencies: The filing includes a standard disclaimer stating that the information in the report and exhibits is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liability of that section, except as expressly set forth by specific reference.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, EPS) by reviewing the attached Exhibit 99.1 (Conference Call Transcript) or the company's subsequent 10-Q filing.
- Confirm the archived conference call recording on the company website (www.bayfirstfinancial.com) for management's qualitative outlook.
- Check for any forward-looking statements or guidance provided during the July 30, 2025 call that may not be reflected in this summary 8-K.